Drugs · acquisition-cost intelligence
Atrovent HFA
ipratropium bromide· ingredient ipratropiumAnticholinergics· IPRATROPIUM BROMIDE 17 ug/1
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per GM
$22.77
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per GM — the trend nobody else shows. 5 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other ipratropium products, cheapest acquisition cost first. Per GM — confirm strength/form equivalence before switching.
| Product | NADAC / GM | vs this |
|---|---|---|
| Ipratropium bromide | $0.11217 | −$22.66 |
| Ipratropium bromide | $0.38628 | −$22.38 |
| ipratropium bromide | $0.83026 | −$21.94 |
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.